HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minrong Cheng Selected Research

Calnexin

2/2022[Calnexin (CNX) enhances the killing effect of CD8+ T cells on colorectal cancer cells by promoting MHC I expression].
1/2021miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8+ T cell-mediated immune attack in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minrong Cheng Research Topics

Disease

2Neoplasms (Cancer)
02/2022 - 01/2021
2Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

2CalnexinIBA
02/2022 - 01/2021
1Proteins (Proteins, Gene)FDA Link
02/2022
1Immune Checkpoint InhibitorsIBA
01/2021

Therapy/Procedure

1Immunotherapy
01/2021